This is a clinical-stage biopharmaceutical company focussed on the development of drugs and medical devices derived from plants. The company’s pipeline is developed by tracking medical discoveries and medical device technologies developed in research institutions in the Asia-Pacific region. looks for new ideas or technologies in research centers in the Asia-Pacific region to create its products. Drugs in their pipeline target a range of health issues including major depressive disorder (MDD), attention deficit hyperactivity disorder (ADHD), advanced pancreatic cancer and non-small cell lung cancer.